Purchase Order 75D30126P21328

<p>The Centers for Disease Control and Prevention Pittsburgh issued a delivery order to Abbott Molecular Inc. on July 24, 2026, with a ceiling value of $178,276.09 for the purchase of laboratory supplies under Executive Order 14398.</p> <p>The order is issued under the GSA Critical Analyzers, Laboratory (FSS-66-III) schedule. Place of performance is Atlanta, GA 30329. The order is firm fixed price and has an ultimate completion date of October 24, 2026. No set-aside was used for this award.</p>

Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a firm fixed-price purchase order valued at $121,043.36 by the Centers for Disease Control and Prevention (CDC) on June 21, 2024, for delivery by February 1, 2025. The contract procures Abbott M2000 System equipment and related products from Abbott Molecular's Des Plaines, Illinois facility. The Abbott M2000 System is designated by the World Health Organization as the reference method for HIV viral load testing and early...

The Centers for Disease Control and Prevention awarded a purchase order to Abbott Molecular Inc. valued at $122,410.61 on September 19, 2025, for maintenance and support services of m2000 Realtime PCR Platforms at CDC's International Laboratory Branch. Performance will occur at CDC's Roybal Campus in Atlanta, Georgia, with an ultimate completion date of August 30, 2026. The purchase order covers preventive and corrective maintenance, OEM software and firmware updates, quality assurance,...

<p>CDC Pittsburgh awarded a purchase order to Abbott Molecular Inc. for $134,673 on September 28, 2023, for laboratory services under a firm fixed price structure, with ultimate completion on September 27, 2028. Work is performed in Atlanta, Georgia. No set-aside was used. Abbott Molecular, a subsidiary of Abbott Laboratories, is a large for-profit manufacturer of in-vitro diagnostic substances and laboratory instrumentation with no small business certifications.</p>

The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a purchase order to Abbott Molecular Inc. for a yearly service agreement for the Abbott Alinity M NAT system valued at $160,552.75, effective June 15, 2023, with an ultimate completion date of June 14, 2028. No set-aside applied. Performance occurs in Atlanta, Georgia. The Alinity M platform delivers nucleic acid testing (NAT) capability for molecular diagnostics. This is a firm fixed price acquisition executed as a...

This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and consumables for in-vitro diagnostics. The contract has a ceiling value of $82,161.09 and was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract is a delivery order under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test Kits. It does not have a set-aside designation. Abbott Molecular is a large, for-profit manufacturer...

This federal contract award is to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The contract has a potential value of $145,589.00 and is a Delivery Order under the Critical Analyzers, Laboratory GSA Schedule contract. The contract does not have a set-aside designation. Through this award, Abbott...

This federal contract award is for the provision of HIV RNA extraction equipment, HIV amplification controls, calibrators, and related supplies. The contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The award has a ceiling value of $76,942.47 and a completion date of September 15, 2020. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA)...

<p>The CDC Pittsburgh awarded a purchase order to Illumina, Inc. for lab equipment valued at $197,052.50 on August 11, 2022, with an ultimate completion date of August 31, 2027. No set-aside was used. Performance occurs in San Diego, California. The procurement is firm fixed price and covers DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software under Executive Order 14398.</p>

<p>The CDC Pittsburgh awarded a purchase order to Agilent Technologies Inc., Customer Service and Sales Division, valued at $75,957.84 on May 14, 2026, for analytical laboratory equipment or consumables with a completion date of May 13, 2027.</p> <p>Work will be performed in Atlanta, Georgia. The order carries firm fixed price terms and uses no set-aside category. No solicitation reference or detailed requirement scope is provided in the source.</p>